Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials

被引:0
|
作者
Laukhtina, E. [1 ]
Mori, K. [2 ]
Mostafaei, H. [2 ]
Merseburger, A. S. [3 ]
Nyirady, P. [4 ]
Moschini, M. [5 ]
Quhal, F. [2 ]
Pradere, B. [2 ]
Sari, Motlagh R. [2 ]
Schuettfort, V. M. [2 ]
Enikeev, D. [1 ]
Shariat, S. F. [2 ]
机构
[1] Sechenov Univ, Inst Urol & Reprod Hlth, Moscow, Russia
[2] Med Univ Vienna, Dept Urol, Vienna, Austria
[3] Univ Hosp Schleswig Holstein, Dept Urol, Lubeck, Germany
[4] Semmelweis Univ, Dept Urol, Budapest, Hungary
[5] Luzerner Kantonsspital, Dept Urol, Luzern, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
P0834
引用
收藏
页码:S1164 / S1165
页数:2
相关论文
共 50 条
  • [21] Efficacy of different chemotherapy regimens in treatment of advanced or metastatic pancreatic cancer: A network meta-analysis
    Zhang, Shu-Hua
    Liu, Gui-Feng
    Li, Xue-Feng
    Liu, Lin
    Yu, Shao-Nan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (04) : 3352 - 3374
  • [22] Systematic Literature Review and Meta-Analysis of Response to First-Line Therapies for Advanced/Metastatic Urothelial Cancer Patients Who Are Cisplatin Ineligible
    Freshwater, Tomoko
    Li, Haojie
    Valiathan, Chandni
    Li, Mengyao
    Perini, Rodolfo
    Bracco, Oswaldo L.
    Frenkl, Tara
    Keefe, Stephen
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (10): : 802 - 809
  • [23] The role of immune checkpoint inhibitors in the first-line treatment for patients with advanced biliary tract cancer: a systematic review and meta-analysis of randomized trials
    Vitale, Elsa
    Rizzo, Alessandro
    Maistrello, Lorenza
    Nardulli, Patrizia
    Talienti, Tiziana
    Quaresmini, Davide
    De Summa, Simona
    Massafra, Raffaella
    Silvestris, Nicola
    Brunetti, Oronzo
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [24] Efficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysis
    Gao, Zhen
    Huang, Shujie
    Wang, Sichao
    Tang, Dezhao
    Xu, Wei
    Zeng, Ruijie
    Qiao, Guibin
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 38
  • [25] Checkpoint inhibitors in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs).
    Tun, Aung
    Thein, Wai Lin
    Elfiky, Aymen
    Gasperino, James
    Guevara, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [26] Checkpoint inhibitors in combination with chemotherapy for first-line treatment of advanced non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs).
    Thein, Wai Lin
    Tun, Aung
    Thein, Kyaw Zin
    Guevara, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Adverse events of the second-line treatment for patients with locally advanced or metastatic urothelial carcinoma of the bladder: network meta-analysis
    Laukhtina, Ekaterina
    Mori, Keiichiro
    Mostafaei, Hadi
    Merseburger, Axel S.
    Nyirady, Peter
    Moschini, Marco
    Quhal, Fahad
    Schuettfort, Victor M.
    Pradere, Benjamin
    Motlagh, Reza Sari
    Enikeev, Dmitry
    Shariat, Shahrokh F.
    IMMUNOTHERAPY, 2021, 13 (11) : 917 - 930
  • [28] First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis
    Hess, Lisa M.
    DeLozier, Amy M.
    Natanegara, Fanni
    Wang, Xiaofei
    Soldatenkova, Victoria
    Brnabic, Alan
    Able, Stephen L.
    Brown, Jacqueline
    JOURNAL OF THORACIC DISEASE, 2018, 10 (12) : 6677 - +
  • [29] A network meta-analysis (NMA) of randomized controlled trials (RCT) of chemotherapy regimens for metastatic pancreatic cancer (mPC)
    Gresham, Gillian
    Gill, Sharlene
    Wells, George A.
    Jonker, Derek J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis
    Gillian K Gresham
    George A Wells
    Sharlene Gill
    Christopher Cameron
    Derek J Jonker
    BMC Cancer, 14